Developer docs
API playgroundTry for free, no card

Search company profiles

Novogene

Full company profile

uuid004zo69

Namestring
Novogene
Legal namestring
Novogene Corporation Inc.
Websiteurl
novogene.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Novogene Corporation Inc. is a US-incorporated (California, 2016) multi-omics services provider and the North American operating entity of the broader Novogene Group. The company offers an integrated portfolio spanning genomics (human, plant, animal, microbial WGS/WES; de novo assembly; metagenomics), transcriptomics (mRNA-seq, total RNA-seq, small RNA-seq, ISO-Seq, prokaryotic and metatranscriptomics), single-cell and spatial omics (10x scRNA-seq, Illumina PIP-seq, spatial transcriptomics), epigenomics (WGBS, EM-Seq, DM-Seq, RIP-seq, ChIP-seq, CUT&Tag, ATAC-seq, RRBS), proteomics (DIA quantitative proteomics on Thermo Orbitrap Astral, PTM analysis, Olink), and metabolomics. Services are delivered through two operational production facilities: the Sacramento Sequencing Center (CLIA-certified since 2018, housing NovaSeq X Plus installed in 2023) and the Beaverton Laboratory (opened 2025, with state-of-the-art mass spectrometry). The technology stack integrates six major certified instrumentation platforms (Illumina, PacBio Revio, 10x Genomics, Ultima Genomics, Thermo Fisher Orbitrap Astral, Olink) with proprietary automation (Falcon/Falcon II), an online bioinformatics tool (NovoMagic), and a customer-facing project management system (CSS), supported by 3,034.69 Tflops of high-performance computing capacity.

The business model is a hybrid sales-led / product-led services model. Revenue is generated predominantly on a per-project, per-sample basis (core offering 10x Single Cell RNA-seq from $1,999/sample, 10x Genomics Flex Apex from $899) with optional bioinformatics add-ons, complemented by a self-serve online ordering channel for select services (mRNA-seq, Illumina Lane Sequencing) and an enterprise inside-sales/field-sales motion for complex multi-omics projects. Pricing is promotional with periodic campaigns (e.g., RNA Day 2026 with up to 15% discounts). Customer segments are horizontally distributed across academic institutions, hospitals and clinical research organizations, pharmaceutical and biotechnology companies, and agricultural enterprises, with no disclosed named anchor customers. The company reports 8,000+ organizations served globally, 3M+ samples processed annually, 200,000+ proteomics samples across 250+ species, and 40,000+ scientific publications citing its services, indicating a high-volume, mid-to-low ASP revenue engine.

Short descriptiontext

Novogene Corporation Inc. is a US-based multi-omics services provider offering integrated genomics, transcriptomics, single-cell, epigenomics, proteomics, and metabolomics sequencing from CLIA-certified labs in Sacramento and Beaverton, serving academic, clinical, pharmaceutical, and agricultural customers globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
Headquarters/, /, China
HQ citystring
/, /
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
multi-omics sequencing, genomics services, NGS sequencing, proteomics analysis, bioinformatics platforms
Industry4 codes
PRIMARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Genomics & Multi-omics Sequencing Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1NGS and Multi-Omics Sequencing Services
TypeOne Time License
Description

Project-based laboratory services covering genomics, transcriptomics, epigenomics, proteomics, and metabolomics. Customers submit biological samples and receive sequencing/bioinformatics data. Services are priced per sample or per lane with optional bioinformatics add-ons. Revenue is generated through per-project fees with no recurring subscription component for the core service.

novogeneusa.com
2Bioinformatics Analysis Services
TypeOne Time License
Description

Standardized and customized bioinformatics analysis delivered as an add-on to core sequencing services or as standalone analysis. RNA Day 2026 promotion offers codes for sequencing with/without bioinformatics analysis (10% and 15% off respectively).

novogeneusa.com
3Sequencing-Only Services
TypeOne Time License
Description

Customers with pre-prepared libraries can use Novogene's sequencing platforms (Illumina or Ultima Sequencer) on a per-lane or per-sample basis, with pricing based on sequencing format (PE150) and data release options.

novogeneusa.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details4 tiers
110x Single Cell RNA-seq starting at $1,999/sample (Full Service)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Full Service-10x Single Cell RNA-seq starts at $1,999 per sample. This includes sample processing, library preparation, sequencing, and basic bioinformatics.

novogeneusa.com
210x Genomics Flex Apex starting at $899
ModelUnit PricingBilling cadencePay-as-you-go
Notes

10x Genomics Flex Apex service starts at $899. Pricing depends on specific service package and sample requirements.

novogeneusa.com
3RNA Day 2026 Promotion: Up to 15% off mRNA-seq
ModelUnit PricingBilling cadencePay-as-you-go
Notes

RNA Day 2026 promotional pricing: Promo code RNADAY2026_WBI_15%OFF for sequencing with bioinformatic analysis (up to 15% off); Promo code RNADAY2026_WOBI_10%OFF for sequencing without bioinformatic analysis (up to 10% off). Only one promo code per order; codes cannot be combined.

novogeneusa.com
4Free upgrade or $20 extraction options available via sales representative
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Customers can contact their sales representative for free sample extraction upgrade or $20 extraction options.

novogeneusa.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1Falcon
Description

Proprietary automated intelligent delivery platform that standardizes workflows from sample to data, ensuring reproducibility, rapid turnaround, and flexible project management.

novogeneusa.com
+2 more records
Core offering1 text field

Novogene provides multi-omics sequencing and bioinformatics services, including genomics (whole-genome, exome, targeted sequencing), transcriptomics (RNA-seq, single-cell), epigenomics, proteomics, and metabolomics analysis. The company operates CAP-accredited laboratories with advanced NGS platforms and proprietary data-analysis pipelines (Falcon, NovoMagic) to deliver project-based results for academic, clinical, and industrial research customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 8,000+ organizations served globally
+5 more records
Product overview1 text field

Novogene is a multi-omics services provider offering an integrated portfolio of genomics, transcriptomics, single-cell & spatial omics, epigenomics, proteomics, and metabolomics solutions. The core offerings include Human Whole Genome Sequencing, Whole Exome Sequencing, mRNA Sequencing, 10x Single Cell Gene Expression, Spatial Transcriptomics, Whole Genome Bisulfite Sequencing, Quantitative Proteomics (DIA), and Untargeted Metabolomics. These services are delivered through a technology platform that includes the proprietary Falcon automated delivery system, NovoMagic bioinformatics analysis tool, and Customer Service System. Novogene operates as a certified provider for major technology platforms including 10x Genomics, Illumina, Ultima Genomics, PacBio Revio, Thermo Fisher Orbitrap Astral, and Olink, enabling end-to-end solutions from sample preparation through data delivery. The company processes over 3 million samples annually across 8,000+ organizations served, with high-performance computing infrastructure (3,034.69 Tflops) supporting bioinformatics analysis.

Product and service9 records
1Genomics Sequencing Services
CategoryGenomics Sequencing
Description

Project-based DNA sequencing services covering whole-genome sequencing, whole-exome sequencing, targeted panel sequencing, and resequencing on short-read and long-read platforms, delivered to academic, pharma, and clinical customers.

2Transcriptomics Services
CategoryTranscriptomics
Description

Bulk RNA-seq, mRNA-seq, small RNA-seq, and single-cell transcriptomics services that quantify gene expression and characterize cell populations, primarily for academic and pharma research customers.

3Epigenomics Services
CategoryEpigenomics
Description

Epigenomic profiling services including bisulfite sequencing, ChIP-seq, and ATAC-seq to measure DNA methylation, histone modifications, and chromatin accessibility for research customers.

4Proteomics Services
CategoryProteomics
Description

LC-MS/MS-based proteomics services including protein identification, quantification, and PTM analysis using Orbitrap Astral instruments, supporting biomarker and translational research at scale.

5Metabolomics Services
CategoryMetabolomics
Description

Untargeted and targeted metabolomics profiling using high-resolution mass spectrometry to identify and quantify small molecules in biological samples for research and pharma customers.

6Single-Cell Sequencing Services
CategorySingle-Cell Genomics
Description

Single-cell RNA-seq, single-cell immune profiling, and related single-cell assays using 10x Genomics technology, delivered as a service to academic, pharma, and clinical research teams.

7Falcon Bioinformatics Platform
CategoryBioinformatics Software
Description

Proprietary cloud-based bioinformatics platform that supports data analysis, visualization, and management for Novogene's multi-omics service customers.

8NovoMagic Data Analysis Platform
CategoryBioinformatics Software
Description

Proprietary data-analysis platform that provides standardized pipelines and analytical tools for genomic, transcriptomic, and multi-omics datasets generated through Novogene services.

9Clinical Sequencing (CSS) Service
CategoryClinical Genomics
Description

CAP-accredited clinical sequencing service that delivers validated NGS workflows for hospital labs and clinical research applications, supported by the CSS platform.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-20
Description

Thermo Fisher Scientific is a key technology partner supplying the Orbitrap Astral mass spectrometry platform for Novogene's quantitative proteomics services. The grand opening of Novogene's Beaverton mass spectrometry lab (May 20, 2026) featured Michelle Steel, VP of Sales for the Americas in Thermo Fisher's Chromatography and Mass Spectrometry Division, highlighting strong collaboration. The Orbitrap Astral platform integrates three complementary mass analyzers (quadrupole, Orbitrap, Astral) enabling industry-leading sensitivity and throughput for proteomics analysis.

Recent move12 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

QIAGEN provides genomic services and sample technologies used in NGS and multi-omics workflows, competing with Novogene for sample-prep and bioinformatics-enabled sequencing services for academic and clinical customers.

TypeDirect peer
Description

Eurofins Genomics operates a global genomics services network offering DNA sequencing, gene synthesis, oligonucleotides, and bioinformatics — directly comparable breadth to Novogene with broader geographic coverage in Europe.

TypeDirect peer
Description

Azenta (GENEWIZ) is a U.S.-headquartered NGS and multi-omics services provider serving academic and pharma customers with Sanger, NGS, and synthesis services — directly comparable to Novogene's Sanger/NGS/synthesis offerings.

TypeEmerging player
Description

PacBio is a long-read sequencing platform provider whose Revio instruments Novogene uses as a certified service provider. While primarily an instrument company, PacBio is increasingly offering services and competes for long-read sequencing projects.

TypeBroad incumbent
Description

Thermo Fisher supplies the Orbitrap Astral mass spec platform that Novogene uses for proteomics and is also a broad life sciences tools and services incumbent that competes in adjacent CRO/CDMO and clinical research services markets.

TypeDirect peer
Description

BGI is the largest global NGS services provider and Novogene's most direct competitor, offering comparable genomic, transcriptomic, and multi-omics services at scale across human, plant, animal, and microbial applications. Both are headquartered in/affiliated with China and compete aggressively on price and turnaround.

TypeBroad incumbent
Description

Illumina is the dominant sequencing platform provider whose instruments (including the NovaSeq X Plus installed at Novogene) underpin the entire NGS services market. Through its own services initiatives and BaseSpace, Illumina competes broadly with Novogene and adjacent providers.

TypeDirect peer
Description

Personalis is a cancer-focused genomics services provider offering tumor/normal sequencing, ctDNA, and immune profiling — directly comparable to Novogene's cancer research and pharma biomarker services, with similar CLIA-certified clinical capability.

TypeEmerging player
Description

10x Genomics is a leading single-cell and spatial biology platform provider whose certified service providers (including Novogene) deliver its assays. 10x is increasingly competing downstream via direct service offerings and adjacent products.

TypeDirect peer
Description

NeoGenomics is a clinical oncology-focused genomics services lab offering NGS, IHC, and molecular diagnostics. While more clinically oriented than Novogene, it competes in the same pharma biomarker and clinical genomics services market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Novogene

Genomics & Multi-omics Sequencing Servicesnovogene.com

Novogene Corporation Inc. is a US-based multi-omics services provider offering integrated genomics, transcriptomics, single-cell, epigenomics, proteomics, and metabolomics sequencing from CLIA-certified labs in Sacramento and Beaverton, serving academic, clinical, pharmaceutical, and agricultural customers globally.

What Novogene does

Novogene Corporation Inc. is a US-incorporated (California, 2016) multi-omics services provider and the North American operating entity of the broader Novogene Group. The company offers an integrated portfolio spanning genomics (human, plant, animal, microbial WGS/WES; de novo assembly; metagenomics), transcriptomics (mRNA-seq, total RNA-seq, small RNA-seq, ISO-Seq, prokaryotic and metatranscriptomics), single-cell and spatial omics (10x scRNA-seq, Illumina PIP-seq, spatial transcriptomics), epigenomics (WGBS, EM-Seq, DM-Seq, RIP-seq, ChIP-seq, CUT&Tag, ATAC-seq, RRBS), proteomics (DIA quantitative proteomics on Thermo Orbitrap Astral, PTM analysis, Olink), and metabolomics. Services are delivered through two operational production facilities: the Sacramento Sequencing Center (CLIA-certified since 2018, housing NovaSeq X Plus installed in 2023) and the Beaverton Laboratory (opened 2025, with state-of-the-art mass spectrometry). The technology stack integrates six major certified instrumentation platforms (Illumina, PacBio Revio, 10x Genomics, Ultima Genomics, Thermo Fisher Orbitrap Astral, Olink) with proprietary automation (Falcon/Falcon II), an online bioinformatics tool (NovoMagic), and a customer-facing project management system (CSS), supported by 3,034.69 Tflops of high-performance computing capacity.

The business model is a hybrid sales-led / product-led services model. Revenue is generated predominantly on a per-project, per-sample basis (core offering 10x Single Cell RNA-seq from $1,999/sample, 10x Genomics Flex Apex from $899) with optional bioinformatics add-ons, complemented by a self-serve online ordering channel for select services (mRNA-seq, Illumina Lane Sequencing) and an enterprise inside-sales/field-sales motion for complex multi-omics projects. Pricing is promotional with periodic campaigns (e.g., RNA Day 2026 with up to 15% discounts). Customer segments are horizontally distributed across academic institutions, hospitals and clinical research organizations, pharmaceutical and biotechnology companies, and agricultural enterprises, with no disclosed named anchor customers. The company reports 8,000+ organizations served globally, 3M+ samples processed annually, 200,000+ proteomics samples across 250+ species, and 40,000+ scientific publications citing its services, indicating a high-volume, mid-to-low ASP revenue engine.

Novogene firmographics

Firmographics
Name
Novogene
Legal name
Novogene Corporation Inc.
Website
https://novogene.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Novogene Corporation Inc. is a US-based multi-omics services provider offering integrated genomics, transcriptomics, single-cell, epigenomics, proteomics, and metabolomics sequencing from CLIA-certified labs in Sacramento and Beaverton, serving academic, clinical, pharmaceutical, and agricultural customers globally.
Ownership category
akta.pro rank

Novogene industry classification

Industry
Product category
Genomics & Multi-omics Sequencing Services
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAGANAE
Transcriptomics & Gene Expression Profiling Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Multi-omics sequencing
  • Genomics services
  • NGS sequencing
  • Proteomics analysis
  • Bioinformatics platforms

Where Novogene is headquartered

Location

Headquarters

HQ city
/, /
HQ country
China
HQ region
Asia

Offices4 records

Markets served

Novogene business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. NGS and Multi-Omics Sequencing Services: Project-based laboratory services covering genomics, transcriptomics, epigenomics, proteomics, and metabolomics. Customers submit biological samples and receive sequencing/bioinformatics data. Services are priced per sample or per lane with optional bioinformatics add-ons. Revenue is generated through per-project fees with no recurring subscription component for the core service.
  2. Bioinformatics Analysis Services: Standardized and customized bioinformatics analysis delivered as an add-on to core sequencing services or as standalone analysis. RNA Day 2026 promotion offers codes for sequencing with/without bioinformatics analysis (10% and 15% off respectively).
  3. Sequencing-Only Services: Customers with pre-prepared libraries can use Novogene's sequencing platforms (Illumina or Ultima Sequencer) on a per-lane or per-sample basis, with pricing based on sequencing format (PE150) and data release options.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-go10x Single Cell RNA-seq starting at $1,999/sample (Full Service)
Unit PricingPay-as-you-go10x Genomics Flex Apex starting at $899
Unit PricingPay-as-you-goRNA Day 2026 Promotion: Up to 15% off mRNA-seq
Unit PricingPay-as-you-goFree upgrade or $20 extraction options available via sales representative

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Novogene product offering

Product offering

Core offering

Novogene provides multi-omics sequencing and bioinformatics services, including genomics (whole-genome, exome, targeted sequencing), transcriptomics (RNA-seq, single-cell), epigenomics, proteomics, and metabolomics analysis. The company operates CAP-accredited laboratories with advanced NGS platforms and proprietary data-analysis pipelines (Falcon, NovoMagic) to deliver project-based results for academic, clinical, and industrial research customers.

Product overview

Novogene is a multi-omics services provider offering an integrated portfolio of genomics, transcriptomics, single-cell & spatial omics, epigenomics, proteomics, and metabolomics solutions. The core offerings include Human Whole Genome Sequencing, Whole Exome Sequencing, mRNA Sequencing, 10x Single Cell Gene Expression, Spatial Transcriptomics, Whole Genome Bisulfite Sequencing, Quantitative Proteomics (DIA), and Untargeted Metabolomics. These services are delivered through a technology platform that includes the proprietary Falcon automated delivery system, NovoMagic bioinformatics analysis tool, and Customer Service System. Novogene operates as a certified provider for major technology platforms including 10x Genomics, Illumina, Ultima Genomics, PacBio Revio, Thermo Fisher Orbitrap Astral, and Olink, enabling end-to-end solutions from sample preparation through data delivery. The company processes over 3 million samples annually across 8,000+ organizations served, with high-performance computing infrastructure (3,034.69 Tflops) supporting bioinformatics analysis.

Differentiator

Problem solved

Functional benefit

Brands

  • Falcon: Proprietary automated intelligent delivery platform that standardizes workflows from sample to data, ensuring reproducibility, rapid turnaround, and flexible project management.
  • NovoMagic
  • CSS (Customer Service System)

Products and services

  • Genomics Sequencing Services Project-based DNA sequencing services covering whole-genome sequencing, whole-exome sequencing, targeted panel sequencing, and resequencing on short-read and long-read platforms, delivered to academic, pharma, and clinical customers.
  • Transcriptomics Services Bulk RNA-seq, mRNA-seq, small RNA-seq, and single-cell transcriptomics services that quantify gene expression and characterize cell populations, primarily for academic and pharma research customers.
  • Epigenomics Services Epigenomic profiling services including bisulfite sequencing, ChIP-seq, and ATAC-seq to measure DNA methylation, histone modifications, and chromatin accessibility for research customers.
  • Proteomics Services LC-MS/MS-based proteomics services including protein identification, quantification, and PTM analysis using Orbitrap Astral instruments, supporting biomarker and translational research at scale.
  • Metabolomics Services Untargeted and targeted metabolomics profiling using high-resolution mass spectrometry to identify and quantify small molecules in biological samples for research and pharma customers.
  • Single-Cell Sequencing Services Single-cell RNA-seq, single-cell immune profiling, and related single-cell assays using 10x Genomics technology, delivered as a service to academic, pharma, and clinical research teams.
  • Falcon Bioinformatics Platform Proprietary cloud-based bioinformatics platform that supports data analysis, visualization, and management for Novogene's multi-omics service customers.
  • NovoMagic Data Analysis Platform Proprietary data-analysis platform that provides standardized pipelines and analytical tools for genomic, transcriptomic, and multi-omics datasets generated through Novogene services.
  • Clinical Sequencing (CSS) Service CAP-accredited clinical sequencing service that delivers validated NGS workflows for hospital labs and clinical research applications, supported by the CSS platform.

Quantifiable outcome

  • 8,000+ organizations served globally
  • +5 more outcomes

Companies that use Novogene

Customer profile

Segments8 records

Ideal customer profiles3 records

Novogene technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability4 records

Feature5 records

Novogene partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Thermo Fisher ScientificcoreTechnology or Integration · 20 May 2026Thermo Fisher Scientific is a key technology partner supplying the Orbitrap Astral mass spectrometry platform for Novogene's quantitative proteomics services. The grand opening of Novogene's Beaverton mass spectrometry lab (May 20, 2026) featured Michelle Steel, VP of Sales for the Americas in Thermo Fisher's Chromatography and Mass Spectrometry Division, highlighting strong collaboration. The Orbitrap Astral platform integrates three complementary mass analyzers (quadrupole, Orbitrap, Astral) enabling industry-leading sensitivity and throughput for proteomics analysis.

Scale indicators7 records

Recent moves12 records

Expansion highlights5 records

Novogene competitors and assessment

Company assessment

Direct peers

  • QIAGEN (Genomics Services): QIAGEN provides genomic services and sample technologies used in NGS and multi-omics workflows, competing with Novogene for sample-prep and bioinformatics-enabled sequencing services for academic and clinical customers.
  • Eurofins Genomics: Eurofins Genomics operates a global genomics services network offering DNA sequencing, gene synthesis, oligonucleotides, and bioinformatics — directly comparable breadth to Novogene with broader geographic coverage in Europe.
  • Azenta Life Sciences (formerly GENEWIZ): Azenta (GENEWIZ) is a U.S.-headquartered NGS and multi-omics services provider serving academic and pharma customers with Sanger, NGS, and synthesis services — directly comparable to Novogene's Sanger/NGS/synthesis offerings.
  • BGI Genomics: BGI is the largest global NGS services provider and Novogene's most direct competitor, offering comparable genomic, transcriptomic, and multi-omics services at scale across human, plant, animal, and microbial applications. Both are headquartered in/affiliated with China and compete aggressively on price and turnaround.
  • Personalis: Personalis is a cancer-focused genomics services provider offering tumor/normal sequencing, ctDNA, and immune profiling — directly comparable to Novogene's cancer research and pharma biomarker services, with similar CLIA-certified clinical capability.
  • NeoGenomics: NeoGenomics is a clinical oncology-focused genomics services lab offering NGS, IHC, and molecular diagnostics. While more clinically oriented than Novogene, it competes in the same pharma biomarker and clinical genomics services market.

Emerging players

  • Pacific Biosciences (PacBio): PacBio is a long-read sequencing platform provider whose Revio instruments Novogene uses as a certified service provider. While primarily an instrument company, PacBio is increasingly offering services and competes for long-read sequencing projects.
  • 10x Genomics: 10x Genomics is a leading single-cell and spatial biology platform provider whose certified service providers (including Novogene) deliver its assays. 10x is increasingly competing downstream via direct service offerings and adjacent products.

Broad incumbents

  • Thermo Fisher Scientific: Thermo Fisher supplies the Orbitrap Astral mass spec platform that Novogene uses for proteomics and is also a broad life sciences tools and services incumbent that competes in adjacent CRO/CDMO and clinical research services markets.
  • Illumina: Illumina is the dominant sequencing platform provider whose instruments (including the NovaSeq X Plus installed at Novogene) underpin the entire NGS services market. Through its own services initiatives and BaseSpace, Illumina competes broadly with Novogene and adjacent providers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Novogene social profiles

Digital presence

Novogene compliance and trust

Trust signal

Compliance1 record

Novogene financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Novogene leadership team

Management profile

Number of profiles

Profiles2 records

Novogene funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Novogene M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novogene

What does Novogene do?

Novogene provides multi-omics sequencing and bioinformatics services, including genomics (whole-genome, exome, targeted sequencing), transcriptomics (RNA-seq, single-cell), epigenomics, proteomics, and metabolomics analysis. The company operates CAP-accredited laboratories with advanced NGS platforms and proprietary data-analysis pipelines (Falcon, NovoMagic) to deliver project-based results for academic, clinical, and industrial research customers.

Is Novogene a public or private company?

Novogene is a private company. It is classified as unknown and is currently operating.

When was Novogene founded?

Novogene was founded in 2016. It employs 501 to 1,000 people.

Where is Novogene based?

Novogene is headquartered in /, /, China, in the Asia region.

How does Novogene make money?

Three revenue lines are on record. NGS and Multi-Omics Sequencing Services are the primary driver. The others are bioinformatics Analysis Services and sequencing-Only Services.

Who are Novogene's main competitors?

Direct peers on record are QIAGEN (Genomics Services), Eurofins Genomics, Azenta Life Sciences (formerly GENEWIZ), BGI Genomics, Personalis and NeoGenomics. Emerging players are Pacific Biosciences (PacBio) and 10x Genomics. Broad incumbents are Thermo Fisher Scientific and Illumina.

Does Novogene have an API?

No public API is recorded for Novogene.

What industry is Novogene in?

Novogene's product category is Genomics & Multi-omics Sequencing Services. Its primary akta.pro industry code is HLAFAMAE, Molecular Diagnostics & Genomics Laboratories, with a secondary code of HLAGANAE, Transcriptomics & Gene Expression Profiling Services. Its NAICS code is 5417 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales